An unimmunized 5 -year-old child presents to the OPD with a white membranous layer on inspection, suggesting diphtheria. What is the appropriate prophylaxis for a 2 -year-old contact who has completed their vaccination?
Q2
Which vaccine is contraindicated in a 3-monthold infant with recurrent respiratory illness?
Q3
A child is a known case of HIV with a CD4 count of 50 . Which of the following vaccines should be avoided in this child?
Q4
A girl child has had recurrent yeast and respiratory viral infections since she was 3 months old. Considering studies for her immune status, which of the following vaccines is contraindicated?
Q5
A previously healthy 11-year-old boy is brought to the emergency department because of a 3-day history of fever, cough, and a runny nose. During this period, he has also had pink, itchy eyes. The patient emigrated from Syria 2 weeks ago. His parents died 6 months ago. He has not yet received any routine childhood vaccinations. He lives at a foster home with ten other refugees; two have similar symptoms. He appears anxious and is sweating. His temperature is 39.2°C (102.5°F), pulse is 100/min, respirations are 20/min, and blood pressure is 125/75 mm Hg. Examination shows conjunctivitis of both eyes. There are multiple bluish-gray lesions on an erythematous background on the buccal mucosa and the soft palate. This patient is at increased risk for which of the following complications?
Q6
A 13-month-old girl is brought to the physician because of a pruritic rash for 2 days. The girl's mother says she noticed a few isolated skin lesions on her trunk two days ago that appear to be itching. The girl received her routine immunizations 18 days ago. Her mother has been giving her ibuprofen for her symptoms. The patient has no known sick contacts. She is at the 71st percentile for height and the 64th percentile for weight. She is in no acute distress. Her temperature is 38.1°C (100.6°F), pulse is 120/min, and respirations are 26/min. Examination shows a few maculopapular and pustular lesions distributed over the face and trunk. There are some excoriation marks and crusted lesions as well. Which of the following is the most likely explanation for these findings?
Q7
A 4-year-old girl is brought to her pediatrician for a routine check-up. She was diagnosed with sickle cell disease last year after an episode of dactylitis. She was started on hydroxyurea, with no painful crises or acute chest episodes since starting the medication. Which of the following is an appropriate preventive measure for this patient?
Q8
A 6-year-old girl presents to the clinic for a general checkup before her last scheduled DTaP vaccination. Her mother is concerned about mild swelling and redness at the site of injection after her daughter’s previous DTaP administration. The patient has mild spastic cerebral palsy. She was diagnosed with epilepsy at the age of 5, and it is well-controlled with levetiracetam. She is allergic to penicillin. Currently, she complains of malaise and mild breathlessness. The mother noted that her daughter has been sluggish for the last 3 days. Her vital signs are as follows: the blood pressure is 100/60 mm Hg, the heart rate is 90/min, the respiratory rate is 22/min, and the temperature is 38.8°C (101.8°F). On physical examination, the patient has slightly enlarged submandibular lymph nodes bilaterally and oropharyngeal erythema. On auscultation, there are diminished vesicular breath sounds with a few respiratory crackles over the lower lobe of the left lung. Which of the following factors requires delaying the patient’s vaccination?
Q9
A 2-year-old boy presents for a routine checkup. The patient’s mother says that he has been ‘under the weather’ for the past few days. She did not measure his temperature at home but states that he has felt warm. She denies any episodes of diarrhea or vomiting. No significant past medical history or current medications. The patient attends daycare. He is due for a hepatitis A vaccine. The patient was born at term with no prenatal or perinatal complications. The vital signs include: temperature 37.8°C (100.1°F), blood pressure 112/62 mm Hg, pulse 80/min, respiratory rate 18/min, and oxygen saturation 99% on room air. The patient is alert and responsive. The physical exam is unremarkable. Which of the following is the most appropriate next step in the management of this patient?
Q10
An 11-year-old boy is brought to his pediatrician by his parents for the routine Tdap immunization booster dose that is given during adolescence. Upon reviewing the patient’s medical records, the pediatrician notes that he was immunized according to CDC recommendations, with the exception that he received a catch-up Tdap immunization at the age of 8 years. When the pediatrician asks the boy’s parents about this delay, they inform the doctor that they immigrated to this country 3 years ago from Southeast Asia, where the child had not been immunized against diphtheria, tetanus, and pertussis. Therefore, he received a catch-up series at 8 years of age, which included the first dose of the Tdap vaccine. Which of the following options should the pediatrician choose to continue the boy’s immunization schedule?
Vaccines US Medical PG Practice Questions and MCQs
Question 1: An unimmunized 5 -year-old child presents to the OPD with a white membranous layer on inspection, suggesting diphtheria. What is the appropriate prophylaxis for a 2 -year-old contact who has completed their vaccination?
A. No prophylaxis needed
B. Toxoid
C. Immunoglobulins
D. Penicillin (Correct Answer)
E. Erythromycin
Explanation: ***Penicillin***
- For a **fully vaccinated contact** of a diphtheria case, **antibiotic prophylaxis** (e.g., penicillin or erythromycin) is recommended to prevent carriage and transmission of *Corynebacterium diphtheriae*.
- This approach aims to eradicate the organism from the respiratory tract, even if the contact is otherwise protected from the disease itself.
- **Penicillin** is a commonly used first-line agent for this purpose.
*Erythromycin*
- **Erythromycin** is also an acceptable antibiotic for diphtheria prophylaxis and is particularly useful in penicillin-allergic patients.
- Both penicillin and erythromycin are effective for preventing carriage; the choice between them may depend on local guidelines, patient allergies, and availability.
- In this context, either would be clinically appropriate, but penicillin is often listed as the primary option in standard guidelines.
*No prophylaxis needed*
- This is incorrect because even vaccinated individuals can become **asymptomatic carriers** of *C. diphtheriae* and transmit the infection to unimmunized or under-immunized contacts.
- Prophylaxis is crucial for **breaking the chain of transmission** in a household or close contact setting.
*Toxoid*
- **Diphtheria toxoid** is the active component of the diphtheria vaccine, which stimulates the immune system to produce antibodies against diphtheria toxin, preventing the disease.
- While important for ongoing immunity, administering the toxoid as an immediate prophylaxis for a fully vaccinated contact is not the primary intervention for preventing carriage; **antibiotics are used for this purpose**.
*Immunoglobulins*
- **Diphtheria antitoxin** (DAT), which contains immunoglobulins, is used for the **treatment of active diphtheria disease** by neutralizing the circulating toxin.
- It is not indicated for prophylaxis in vaccinated contacts, as their immune system is already primed to handle potential exposure to the toxin, and the goal of prophylaxis here is to prevent colonization rather than toxin effects.
Question 2: Which vaccine is contraindicated in a 3-monthold infant with recurrent respiratory illness?
A. DT (Diphtheria and Tetanus)
B. Measles vaccine
C. DPT (Diphtheria, Pertussis, Tetanus) (Correct Answer)
D. Inactivated polio vaccine (IPV)
E. Hepatitis B vaccine
Explanation: ***DPT (Diphtheria, Pertussis, Tetanus)***
- While DPT is routinely given in infancy, the **pertussis component** (particularly the whole-cell vaccine formulation) can exacerbate existing **respiratory conditions** or be problematic in infants with a history of **unstable neurological disorders**.
- Recurrent respiratory illness in a 3-month-old may indicate underlying pulmonary compromise, for which the pertussis component's side effects (e.g., fever, fussiness) could be poorly tolerated or confound diagnosis.
*Measles vaccine*
- The measles vaccine (MMR) is typically administered at **12-15 months of age**, not at 3 months.
- Measles vaccine is a **live attenuated vaccine**, but its contraindications are primarily related to severe immunosuppression or recent immunoglobulin receipt, not recurrent respiratory illness in this age group.
*DT (Diphtheria and Tetanus)*
- The DT vaccine (without the pertussis component) is generally considered **safe** for infants and often used if the pertussis component is *contraindicated*.
- This option does not address the specific concern regarding the pertussis component in the context of recurrent respiratory illness.
*Inactivated polio vaccine (IPV)*
- IPV is an **inactivated vaccine**, meaning it contains killed virus, and thus carries a very low risk of vaccine-related adverse events.
- Recurrent respiratory illness is **not a contraindication** for IPV, which is part of routine infant immunization schedules.
*Hepatitis B vaccine*
- Hepatitis B vaccine is an **inactivated vaccine** routinely given at birth and as part of the infant immunization schedule.
- Recurrent respiratory illness is **not a contraindication** for Hepatitis B vaccine, which is safe and well-tolerated in infants.
Question 3: A child is a known case of HIV with a CD4 count of 50 . Which of the following vaccines should be avoided in this child?
A. MMR
B. TT
C. BCG (Correct Answer)
D. DPT
E. OPV
Explanation: ***BCG***
- **BCG vaccine** contains live attenuated bacteria and is **absolutely contraindicated** in severely immunocompromised individuals, such as an **HIV-positive child with a CD4 count of 50**, due to the risk of disseminated BCG infection.
- A **CD4 count of 50** indicates severe immunosuppression (AIDS stage), making live vaccines like BCG extremely unsafe.
- **This is the most strongly contraindicated vaccine** in this clinical scenario.
*MMR*
- **MMR (Measles, Mumps, Rubella) vaccine** is a live attenuated vaccine that is generally contraindicated in **severely immunocompromised HIV patients** with **CD4 count <200 cells/µL**.
- With a **CD4 count of 50**, this vaccine would typically be contraindicated due to severe immunosuppression.
- However, **BCG carries a higher risk** of disseminated infection and is more strongly contraindicated.
*OPV*
- **OPV (Oral Polio Vaccine)** is a live attenuated vaccine and is contraindicated in **immunocompromised individuals** including those with severe HIV infection.
- However, most vaccination programs now use **IPV (Inactivated Polio Vaccine)** which is safe for HIV-positive children.
- **BCG remains the most critical contraindication** in severe immunosuppression.
*TT*
- **TT (Tetanus Toxoid)** is an inactivated vaccine containing no live organisms and is **safe for immunocompromised individuals**, including those with HIV.
- Inactivated vaccines are generally recommended for HIV-positive individuals to provide protection against common infections.
*DPT*
- **DPT (Diphtheria, Pertussis, Tetanus)** is an inactivated vaccine and is **safe for immunocompromised children** with HIV.
- It does not pose a risk of infection from the vaccine itself and is crucial for protecting against these severe childhood diseases.
Question 4: A girl child has had recurrent yeast and respiratory viral infections since she was 3 months old. Considering studies for her immune status, which of the following vaccines is contraindicated?
A. Killed IPV (Inactivated Poliovirus Vaccine)
B. DPT (Diphtheria, Pertussis, Tetanus)
C. TT/Td (Tetanus toxoid)
D. Measles/MMR (Correct Answer)
E. Hepatitis B vaccine
Explanation: ***Measles/MMR***
- This patient's history of **recurrent yeast and respiratory viral infections** suggests a potential **immunodeficiency**, which is a contraindication for **live attenuated vaccines** like MMR (Measles, Mumps, Rubella).
- Administering live attenuated vaccines to immunocompromised individuals can lead to **uncontrolled replication of the vaccine virus**, causing severe disease.
*Killed IPV (Inactivated Poliovirus Vaccine)*
- **Inactivated vaccines** do not contain live viruses and are generally safe for immunocompromised individuals.
- The patient's underlying immune status does not contraindicate killed vaccines, as there is **no risk of vaccine-induced infection**.
*DPT (Diphtheria, Pertussis, Tetanus)*
- DPT is a **non-live vaccine** (consisting of toxoids and inactivated bacterial components), making it safe for individuals with immunodeficiency.
- These vaccines do not pose a risk of causing the disease in immunocompromised patients, even if their **immune response is suboptimal**.
*TT/Td (Tetanus toxoid)*
- Tetanus toxoid vaccines are **inactivated vaccines** and are therefore safe for individuals with impaired immune function.
- The concern with immunodeficiency is the **ability to mount an effective immune response**, not the safety of the vaccine itself.
*Hepatitis B vaccine*
- Hepatitis B is a **recombinant inactivated vaccine** that is safe for immunocompromised patients.
- While the vaccine may have **reduced immunogenicity** in this population, it is not contraindicated and does not pose a risk of vaccine-induced disease.
Question 5: A previously healthy 11-year-old boy is brought to the emergency department because of a 3-day history of fever, cough, and a runny nose. During this period, he has also had pink, itchy eyes. The patient emigrated from Syria 2 weeks ago. His parents died 6 months ago. He has not yet received any routine childhood vaccinations. He lives at a foster home with ten other refugees; two have similar symptoms. He appears anxious and is sweating. His temperature is 39.2°C (102.5°F), pulse is 100/min, respirations are 20/min, and blood pressure is 125/75 mm Hg. Examination shows conjunctivitis of both eyes. There are multiple bluish-gray lesions on an erythematous background on the buccal mucosa and the soft palate. This patient is at increased risk for which of the following complications?
A. Coronary artery aneurysm
B. Subacute sclerosing panencephalitis (Correct Answer)
C. Immune thrombocytopenic purpura
D. Non-Hodgkin lymphoma
E. Aplastic crisis
Explanation: ***Subacute sclerosing panencephalitis***
- This patient presents with classic symptoms of **measles** (rubeola): fever, cough, runny nose (coryza), conjunctivitis, and especially the pathognomonic **Koplik spots** (bluish-gray lesions on an erythematous background on buccal mucosa). His unvaccinated status, recent immigration from a region with potentially lower vaccination rates, and exposure to other symptomatic individuals further support this diagnosis.
- **Subacute sclerosing panencephalitis (SSPE)** is a rare, devastating, and fatal complication of measles, caused by persistent measles virus infection in the brain. It typically develops years after the initial measles infection.
*Coronary artery aneurysm*
- **Coronary artery aneurysms** are a classic complication of **Kawasaki disease**, which is characterized by fever, conjunctivitis, oral mucosal changes (strawberry tongue, cracked lips), rash, and cervical lymphadenopathy.
- While there is conjunctivitis, the presence of **Koplik spots** and the typical "cough, coryza, conjunctivitis" prodrome are highly indicative of measles, not Kawasaki disease.
*Immune thrombocytopenic purpura*
- **Immune thrombocytopenic purpura (ITP)** is a disorder causing isolated low platelet count due to autoimmune destruction of platelets, leading to easy bruising and bleeding. It can be triggered by viral infections, but it is not a direct or specific complication of measles itself.
- The patient's symptoms are primarily respiratory and mucocutaneous, with no indication of bleeding or bruising associated with thrombocytopenia.
*Non-Hodgkin lymphoma*
- **Non-Hodgkin lymphoma** is a type of cancer that originates in lymphocytes, a type of white blood cell. While some viral infections (e.g., Epstein-Barr virus, HIV) are associated with an increased risk of specific lymphomas, measles itself is not directly linked to a significant increased risk of non-Hodgkin lymphoma.
- The current clinical picture points to an acute viral infection and its potential long-term neurological sequelae, not a malignancy.
*Aplastic crisis*
- An **aplastic crisis** is a sudden, severe reduction in red blood cell production, most commonly triggered by **Parvovirus B19 infection** in individuals with underlying chronic hemolytic anemias (e.g., sickle cell disease, hereditary spherocytosis).
- The patient's symptoms are characteristic of measles, not parvovirus, and there is no information to suggest an underlying hemolytic anemia.
Question 6: A 13-month-old girl is brought to the physician because of a pruritic rash for 2 days. The girl's mother says she noticed a few isolated skin lesions on her trunk two days ago that appear to be itching. The girl received her routine immunizations 18 days ago. Her mother has been giving her ibuprofen for her symptoms. The patient has no known sick contacts. She is at the 71st percentile for height and the 64th percentile for weight. She is in no acute distress. Her temperature is 38.1°C (100.6°F), pulse is 120/min, and respirations are 26/min. Examination shows a few maculopapular and pustular lesions distributed over the face and trunk. There are some excoriation marks and crusted lesions as well. Which of the following is the most likely explanation for these findings?
A. Antigen contact with presensitized T-lymphocytes
B. Reactivation of virus dormant in dorsal root ganglion
C. Immune complex formation and deposition
D. Crosslinking of preformed IgE antibodies
E. Replication of the attenuated vaccine strain (Correct Answer)
Explanation: ***Replication of the attenuated vaccine strain***
- The presentation of a **pruritic rash with maculopapular and pustular lesions**, along with crusted lesions, describes the classic **polymorphic rash** of **varicella (chickenpox)**.
- The timing of the rash, appearing **18 days after routine immunizations** (which commonly include the attenuated **MMRV vaccine** at 12-15 months), strongly suggests a vaccine-induced varicella rash due to the replication of the live attenuated virus.
*Antigen contact with presensitized T-lymphocytes*
- This mechanism describes a **Type IV hypersensitivity reaction** (delayed-type hypersensitivity), such as **contact dermatitis** or a **tuberculin skin test**.
- While it can cause a rash, it typically presents differently (e.g., vesicles in contact dermatitis) and the timeline of 18 days post-vaccination is less consistent with a primary contact-mediated reaction causing widespread varicella-like lesions.
*Reactivation of virus dormant in dorsal root ganglion*
- This process describes the pathogenesis of **herpes zoster (shingles)**, which occurs due to the reactivation of the **latent varicella-zoster virus (VZV)** from the dorsal root ganglia.
- Shingles typically presents with a **dermatomal rash** in older individuals or immunocompromised patients, not a widespread polymorphic rash in an otherwise healthy toddler.
*Immune complex formation and deposition*
- This mechanism describes a **Type III hypersensitivity reaction**, where antigen-antibody complexes deposit in tissues, leading to inflammation.
- Conditions like **serum sickness**, **lupus**, or some forms of **vasculitis** are examples, which present with fever, arthralgia, and urticarial or purpuric rashes, differing from the described varicella-like lesions.
*Crosslinking of preformed IgE antibodies*
- This mechanism describes a **Type I hypersensitivity reaction**, commonly known as an **allergic reaction**.
- It typically results in **urticaria (hives)**, angioedema, or anaphylaxis, which are acute reactions characterized by wheals and pruritus, rather than the polymorphic rash with pustules and crusts seen here.
Question 7: A 4-year-old girl is brought to her pediatrician for a routine check-up. She was diagnosed with sickle cell disease last year after an episode of dactylitis. She was started on hydroxyurea, with no painful crises or acute chest episodes since starting the medication. Which of the following is an appropriate preventive measure for this patient?
A. Splenectomy
B. Intranasal influenza vaccine
C. Human papillomavirus vaccine
D. Pneumococcal vaccine (Correct Answer)
E. Parenteral penicillin G
Explanation: ***Pneumococcal vaccine***
- Children with **sickle cell disease** are at high risk of severe **pneumococcal infections** due to functional asplenia, making vaccination crucial.
- The **pneumococcal conjugate vaccine (PCV13)** and **pneumococcal polysaccharide vaccine (PPSV23)** are recommended to protect against *Streptococcus pneumoniae*.
*Splenectomy*
- Although **functional asplenia** is common in sickle cell disease, prophylactic splenectomy is *not* a routine recommendation due to the associated risks and the availability of other preventive measures.
- **Splenectomy** is generally reserved for specific indications such as refractory **splenic sequestration crises** or hypersplenism.
*Intranasal influenza vaccine*
- The **intranasal live attenuated influenza vaccine (LAIV)** is **contraindicated** in children with sickle cell disease because of concerns about the live virus potentially exacerbating disease complications.
- The **inactivated influenza vaccine (IIV)**, given intramuscularly, is recommended annually for these patients.
*Human papillomavirus vaccine*
- The **HPV vaccine** is important for preventing cervical cancer and other HPV-related conditions, but it is typically indicated for adolescents starting at age 11 or 12, not a 4-year-old.
- It is not a primary or immediate preventive measure for the acute complications associated with **sickle cell disease** in early childhood.
*Parenteral penicillin G*
- While **oral penicillin prophylaxis** (penicillin V) is indeed recommended for children with sickle cell disease from infancy until at least age 5 to prevent pneumococcal sepsis, this question asks about **parenteral** penicillin G.
- **Parenteral penicillin G** (given by injection) is reserved for treating active infections or specific situations where oral administration is not feasible, not for routine daily prophylaxis in a stable outpatient.
- The standard prophylaxis is **oral penicillin V**, taken twice daily at home.
Question 8: A 6-year-old girl presents to the clinic for a general checkup before her last scheduled DTaP vaccination. Her mother is concerned about mild swelling and redness at the site of injection after her daughter’s previous DTaP administration. The patient has mild spastic cerebral palsy. She was diagnosed with epilepsy at the age of 5, and it is well-controlled with levetiracetam. She is allergic to penicillin. Currently, she complains of malaise and mild breathlessness. The mother noted that her daughter has been sluggish for the last 3 days. Her vital signs are as follows: the blood pressure is 100/60 mm Hg, the heart rate is 90/min, the respiratory rate is 22/min, and the temperature is 38.8°C (101.8°F). On physical examination, the patient has slightly enlarged submandibular lymph nodes bilaterally and oropharyngeal erythema. On auscultation, there are diminished vesicular breath sounds with a few respiratory crackles over the lower lobe of the left lung. Which of the following factors requires delaying the patient’s vaccination?
A. Cerebral palsy
B. Mild swelling and redness at the site of injection after the previous vaccine administration
C. Signs of pneumonia (Correct Answer)
D. Penicillin allergy
E. Epilepsy
Explanation: ***Signs of pneumonia***
- The patient's symptoms (malaise, breathlessness, fever, submandibular lymphadenopathy, oropharyngeal erythema, diminished breath sounds, and crackles) are indicative of an **acute, moderate-to-severe illness**, most likely pneumonia.
- A definitive acute illness, such as suspected pneumonia, is a **precaution** for vaccine administration, warranting a delay until symptoms resolve to avoid attributing worsening symptoms to the vaccine or compounding the illness.
- Per **CDC/ACIP guidelines**, moderate-to-severe acute illness (with or without fever) is a precaution for all vaccines.
*Cerebral palsy*
- **Cerebral palsy** is a chronic, stable neurological condition and is generally **not a contraindication or precaution** for routine vaccinations, including DTaP.
- Patients with cerebral palsy should receive recommended vaccines to prevent infectious diseases, as they may be at increased risk for complications from these infections.
*Mild swelling and redness at the site of injection after the previous vaccine administration*
- **Mild local reactions** (redness, swelling, tenderness) at the injection site are common and **expected side effects** of many vaccines, including DTaP.
- Such mild reactions are **not considered a contraindication or precaution** for subsequent doses.
*Penicillin allergy*
- An allergy to penicillin is generally **not relevant** to vaccine administration, as vaccines do not contain penicillin or related antibiotics.
- The DTaP vaccine does not contain components that would cross-react with a penicillin allergy.
*Epilepsy*
- **Well-controlled epilepsy**, especially when managed with medication like levetiracetam, is **not a contraindication or precaution** for vaccination.
- Most vaccines are safe for individuals with epilepsy, and the benefit of preventing infectious diseases outweighs any theoretical risk.
Question 9: A 2-year-old boy presents for a routine checkup. The patient’s mother says that he has been ‘under the weather’ for the past few days. She did not measure his temperature at home but states that he has felt warm. She denies any episodes of diarrhea or vomiting. No significant past medical history or current medications. The patient attends daycare. He is due for a hepatitis A vaccine. The patient was born at term with no prenatal or perinatal complications. The vital signs include: temperature 37.8°C (100.1°F), blood pressure 112/62 mm Hg, pulse 80/min, respiratory rate 18/min, and oxygen saturation 99% on room air. The patient is alert and responsive. The physical exam is unremarkable. Which of the following is the most appropriate next step in the management of this patient?
A. Order a complete blood count
B. Order liver function tests
C. Strep rapid antigen detection test
D. Administer the hepatitis A vaccine (Correct Answer)
E. Delay the hepatitis A immunization until next visit
Explanation: ***Administer the hepatitis A vaccine***
- The patient has a **low-grade fever** (37.8°C), which is generally **not considered a contraindication** for vaccination, especially if the child is otherwise well and active.
- The patient's presentation of being "under the weather" with an unremarkable physical exam and stable vitals suggests a **mild illness**, allowing for routine vaccinations to proceed.
*Order a complete blood count*
- A **CBC is not indicated** at this time, as the patient displays only mild, non-specific symptoms and has a normal physical exam.
- This would be reserved for cases with more concerning signs of infection or systemic illness, such as persistent high fever, lethargy, or specific clinical findings.
*Order liver function tests*
- **Liver function tests are not warranted** as the patient has no symptoms or signs suggestive of liver disease (e.g., jaundice, right upper quadrant pain, dark urine).
- While the patient is due for a hepatitis A vaccine, there is no clinical evidence of active hepatitis or liver dysfunction requiring diagnostic workup.
*Strep rapid antigen detection test*
- The patient has **no symptoms consistent with streptococcal pharyngitis**, such as sore throat, tonsillar exudates, or cervical lymphadenopathy.
- Given the lack of specific symptoms, testing for strep throat would be inappropriate and potentially lead to unnecessary antibiotic use.
*Delay the hepatitis A immunization until next visit*
- Delaying vaccination is only recommended for **moderate to severe acute illnesses** with or without fever, or for certain contraindications.
- A mild illness with low-grade fever, as in this case, is generally **not a reason to postpone** routine immunizations, as per CDC guidelines.
Question 10: An 11-year-old boy is brought to his pediatrician by his parents for the routine Tdap immunization booster dose that is given during adolescence. Upon reviewing the patient’s medical records, the pediatrician notes that he was immunized according to CDC recommendations, with the exception that he received a catch-up Tdap immunization at the age of 8 years. When the pediatrician asks the boy’s parents about this delay, they inform the doctor that they immigrated to this country 3 years ago from Southeast Asia, where the child had not been immunized against diphtheria, tetanus, and pertussis. Therefore, he received a catch-up series at 8 years of age, which included the first dose of the Tdap vaccine. Which of the following options should the pediatrician choose to continue the boy’s immunization schedule?
A. A single dose of Td vaccine at 18 years of age
B. A single dose of Td vaccine now
C. No further vaccination needed
D. A single dose of Tdap vaccine now
E. A single dose of Tdap vaccine at 13 years of age (Correct Answer)
Explanation: ***A single dose of Tdap vaccine at 13 years of age***
- The CDC recommends a **minimum interval of 5 years** between Tdap doses when Tdap is given as part of a catch-up series.
- Since this patient received his first Tdap at age 8, the earliest he should receive the adolescent booster is at **age 13** (5 years later).
- This timing ensures adequate spacing while still providing the recommended adolescent booster for **pertussis, tetanus, and diphtheria** protection.
- The 5-year interval prevents excessive antigen exposure and optimizes immune response.
*A single dose of Tdap vaccine now*
- Giving Tdap now would result in only a **3-year interval** from the previous Tdap dose at age 8.
- This violates the CDC recommendation of a **minimum 5-year interval** between Tdap doses.
- Shorter intervals may increase local reactogenicity without improving protection.
*A single dose of Td vaccine now*
- While this would provide tetanus and diphtheria protection, it would **not protect against pertussis**, which is a critical component of adolescent vaccination.
- The Tdap vaccine is specifically recommended for adolescents to boost waning pertussis immunity.
- Additionally, giving it now would still be earlier than the recommended 5-year interval from the previous pertussis-containing vaccine.
*A single dose of Td vaccine at 18 years of age*
- This option would result in a **10-year gap** from the last pertussis-containing vaccine, leaving the adolescent vulnerable during high-risk years.
- The adolescent Tdap booster is specifically timed for ages 11-13 to protect during peak transmission periods in middle and high school.
- Waiting until 18 would miss the critical window for pertussis protection.
*No further vaccination needed*
- While the patient completed a catch-up series, the CDC still recommends an **adolescent Tdap booster** even for those who received Tdap in a catch-up series.
- The adolescent booster is important to maintain immunity against pertussis, which wanes significantly over time.
- The booster should be given at age 13 to maintain the 5-year minimum interval.
